期刊文献+

胎儿宫内生长受限彩超血流动力学变化及不良妊娠结局预测模型构建

Hemodynamic changes of fetal intrauterine growth restriction and construction of prediction model for poor pregnancy outcomes
原文传递
导出
摘要 目的探究胎儿生长受限(FGR)脐动脉、大脑中动脉及静脉导管血流动力学变化,并构建FGR不良妊娠结局的预测模型。方法回顾性分析2019年2月至2022年1月于成都医学院第二附属医院·核工业四一六医院分娩的197例FGR孕妇(FGR组)及75例健康孕妇(对照组)的临床资料,所有孕妇均接受了彩色多普勒超声检查;均随访至妊娠结局,采用Logistic回归分析不良妊娠结局发生的危险因素,并建立预测模型,以ROC曲线分析该模型对不良妊娠结局的预测价值。结果FGR组脐动脉搏动指数(PI)、阻力指数(RI)、收缩期最大血流速度与舒张期末血流速度的比值(S/D)及静脉导管S/a值大于对照组,大脑中动脉PI、RI、S/D及静脉导管S峰流速、a峰流速小于对照组(P<0.05);纳入Logistic回归进行分析,发现不良妊娠史、脑胎盘率<1、静脉导管波谱异常、PLGF低于正常值、存在妊娠合并症、宫内感染是导致不良妊娠结局发生的危险因素(P<0.05),并获得FGR孕妇发生不良妊娠结局的风险预测模型,P=-1.053+0.492×不良妊娠史赋值+0.635×脑胎盘率赋值+0.473×静脉导管波谱赋值+0.614×PIGF赋值+0.535×妊娠合并症赋值+0.821×宫内感染赋值,ROC曲线显示,该模型预测FGR孕妇发生不良妊娠结局的AUC为0.929,SE为0.022,95%CI为0.886~0.973。结论FGR孕妇存在脐动脉、大脑中动脉及静脉导管血流异常现象,基于FGR孕妇不良结局的危险因素建立的预测模型,对不良妊娠结局的发生具有较高的预测价值。 Objective To explore the hemodynamic changes of umbilical artery,middle cerebral artery and venous duct in fetal growth restriction(FGR),and to construct a prediction model for poor pregnancy outcomes of FGR.Methods The clinical data of 197 pregnant women with FGR(FGR group)and 75 healthy pregnant women(control group)who gave birth in the 2nd Affiliated Hospital of Chengdu Medical College,Nuclear Industry 416 Hospital from February 2019 to January 2022 were retrospectively analyzed.All patients received color Doppler ultrasound.All pregnant women were followed up to the pregnancy outcome.Logistic regression analysis was used to analyze the risk factors for poor pregnancy outcomes,and the prediction model was established and ROC curve was adopted to analyze the predictive value of the prediction model on poor pregnancy outcomes.Results The pulsatility index(PI),resistance index(RI)and systolic phase/diastolic phase(S/D)of umbilical artery and venous duct S/a value in FGR group were higher while the PI,RI and S/D of middle cerebral artery and S peak flow velocity and a peak flow velocity of venous duct were lower than those in control group(P<0.05).Logistic regression analysis showed that poor pregnancy history,brain placenta rate<1,abnormal spectrum of venous duct,PLGF lower than normal value,presence of pregnancy complications and intrauterine infection were risk factors for poor pregnancy outcomes(P<0.05).The risk prediction model for poor pregnancy outcomes in pregnant women with FGR was obtained and represented as P=-1.053+0.492×poor pregnancy history+0.635×brain placental rate+0.473×abnormal spectrum of venous duct+0.614×PLGF+0.535×pregnancy complications+0.821×intrauterine infection.ROC curve revealed that the AUC,SE and 95%CI of the prediction model in predicting poor pregnancy outcomes in pregnant women with FGR were 0.929,0.022 and 0.886-0.973.Conclusions Pregnant women with FGR have abnormal blood flow phenomena in umbilical artery,middle cerebral artery and venous duct.The prediction model established according to the risk factors of poor outcomes in pregnant women with FGR has high predictive value on the occurrence of poor pregnancy outcomes.
作者 吴雪辉 陆欢 杨智玲 梅劼 WU Xuehui;LU Huan;YANG Zhiling;MEI Jie(School of Clinical Medicine,Southwest Medical University,Luzhou Sichuan 646000,China;Department of Obstetrics and Gynecology,The 2nd Affiliated Hospital of Chengdu Medical College,Nuclear Industry 416 Hospital,Chengdu Sichuan 610057,China;Department of Obstetrics and Gynecology,Sichuan Provincial People's Hospital,Chengdu Sichuan 610000,China)
出处 《中国妇产科临床杂志》 CSCD 北大核心 2024年第5期453-456,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 四川省科学技术厅项目(2022NSFSC0776) 四川省成都市卫生健康委员会科研课题(2022444)。
关键词 胎儿生长受限 血流动力学 妊娠结局 预测模型 fetal growth restriction hemodynamics pregnancy outcomes prediction model
  • 相关文献

参考文献6

二级参考文献56

  • 1American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 2Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 3Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 4Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 5Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 6Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 7Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.
  • 8Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451.
  • 9McCoy S, Baldwin K. Pharmacotherapeutie options for the treatment of preeelampsia[J]. Am J Health Syst Pharm, 2009, 66(4):337-344.
  • 10Duley L, Gfilmezoglu AM, Chou D. Magnesium sulphate versus lytic cocktail for eclampsia[J]. Cochrane Database Syst Rev, 2010, 8(9):CD002960.

共引文献1868

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部